T 1597/22 (Solid dosage from comprising cytisine / AFLOFARM) of 06.12.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T159722.20241206
- Date of decision
- 6 December 2024
- Case number
- T 1597/22
- Online on
- 17 December 2024
- Petition for review of
- -
- Application number
- 13826599.6
- IPC class
- A61K 9/48A61K 31/435A61K 9/14
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- SOLID DOSAGE FORM COMPRISING MICRONIZED CYTISINE
- Applicant name
- Aflofarm Farmacja Polska SP. Z O.O.
- Opponent name
- Reddie & Grose LLP
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- Rules of procedure of the Boards of Appeal 2020 Art 012(4)RPBA 2020 Art 012(6)Rules of procedure of the Boards of Appeal 2020 Art 012(2)Rules of procedure of the Boards of Appeal 2020 Art 011European Patent Convention Art 123(2)European Patent Convention R 139European Patent Convention Art 84European Patent Convention Art 83European Patent Convention Art 111(1)
- Keywords
- Late-filed evidence - admitted (yes)
Amendments - allowable (yes)
Claims - clarity and conciseness after amendment (yes)
Sufficiency of disclosure - (yes)
Remittal - special reasons for remittal (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The case is remitted to the opposition division for further prosecution.